# Abbott Laboratories: Form 8-K, filed Apr 27, 2026

- Company: [Abbott Laboratories](/companies/abt.md) (CIK 1800)
- Form: 8-K
- Filed: 2026-04-27
- Accepted by EDGAR: Apr 27, 2026, 16:06 ET
- Period: 2026-04-24
- Accession: 0001104659-26-049434
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1800/000110465926049434/tm2612318d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1800/000110465926049434/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1800/000110465926049434/tm2612318d1_8k.htm

Filed Apr 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-049434. Last ingested by Listed: Nov 6, 2026, 18:17 ET. No prices; not investment advice.